|
Volumn 53, Issue 4, 2001, Pages 422-428
|
Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
DIPHTHERIA TETANUS VACCINE;
GAMMA INTERFERON;
INTERLEUKIN 4;
INTERLEUKIN 5;
PNEUMOCOCCUS POLYSACCHARIDE;
PNEUMOCOCCUS VACCINE;
POLYSACCHARIDE VACCINE;
ADULT;
ANTIGEN SPECIFICITY;
ARTICLE;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CONJUGATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
FEMALE;
HUMAN;
IMMUNIZATION;
IMMUNOGENICITY;
LYMPHOCYTE PROLIFERATION;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
TH1 CELL;
TH2 CELL;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
ALUMINUM;
DIPHTHERIA-TETANUS VACCINE;
FEMALE;
HUMANS;
IMMUNITY, CELLULAR;
INTERFERON TYPE II;
INTERLEUKIN-4;
INTERLEUKIN-5;
LYMPHOCYTE ACTIVATION;
MALE;
PNEUMOCOCCAL VACCINES;
TH1 CELLS;
TH2 CELLS;
VACCINES, CONJUGATE;
|
EID: 0035062745
PISSN: 03009475
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-3083.2001.00882.x Document Type: Article |
Times cited : (30)
|
References (28)
|